ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

ASIA-PACIFIC AMNIOTIC MEMBRANE MARKET 2022-2028

MARKET OUTLOOK

Triton Market Research’s report on the Asia-Pacific amniotic membrane market estimates the market to progress at a CAGR of 7.67% during the forecasted period 2022-2028. Australia & New Zealand, Japan, South Korea, India, China, ASEAN countries, and Rest of APAC shape the market in the region.

India is estimated to account for around 11% of deaths in road accidents in the world, as per the World Bank. Moreover, the country registers over 4.5 lakh road accidents, resulting in a high volume of surgeries. In this regard, amniotic membrane is widely used in bone transplantation, tissue transplantation, and eye damage. Furthermore, the country witnessed a rise in cosmetic surgery trends over the years, owing to a rise in video-based communication. This has increased the demand for amniotic membrane in cosmetic procedures. Therefore, such spikes are estimated to drive the amniotic membrane market’s growth over the forecast period.

On the other hand, South Korea is witnessing a surge in the geriatric population, leading to a rise in chronic wound cases. The country has advanced in wound care treatment significantly, owing to growth in biotechnology and information technology. Besides, the country has shown significant development in research of cell-based treatments for wound management with the help of the amniotic membrane. Many researchers are innovating, ensuring successful amniotic membrane transplantation surgery without any complications. Thus, these factors support the South Korean amniotic membrane market.


COMPETITIVE OUTLOOK

The well-known companies in the amniotic membrane market include Katena Products Inc, Bio Tissue Inc, Labtician Ophthalmics Inc, Sky Biologics LLC, MiMedx, and Surgenix LLC.